1A9bnbK

***
KEY INTERVENTIONS: SITUATION REPORT − CHAPTER 3
61
Table. 3.4.1 Control of four NTDs with prominent zoonotic characteristics: interventions, obstacles and ultimate objectives
Disease Disease-specific obstacle Ultimate objective Expected result
ECHINOCOCCOSIS
A validated control strategy
implemented in selected countries
through pilot projects (2015)
A validated control strategy
and scaled-up interventions
implemented in selected countries
(2020)
FOODBORNE TREMATODIASES
Inclusion of foodborne
trematodiasesin a mainstream
preventive chemotherapy strategy
75% of the population at
risk covered by preventive
chemotherapy and transmission
control (2020)
RABIES
Elimination of human dog-mediated
rabies in Latin America (2015)
Elimination of human rabies transmitted
by dogs in the South-East
Asia and Western Pacifi c regions
(2015)
TAENIASIS AND (NEURO)CYSTICERCOSIS
A validated strategy for control
and elimination of Taenia solium
taeniasis and (neuro)cysticercosis
(2015)
Lack of tools in peripheral health
centres for early diagnosis
Weak political commitment and
veterinary sector involvement;
inadequate availability or absence
of case detection tools, vaccines
and medicines
The long-term commitment
needed to measure the impact of
interventions
Inadequate availability of medicines
to treat clonorchiasis and
opisthorchiasis
The diffi culty of establishing links
with the veterinary sector
Maintaining support for elimination
programmes where elimination is
imminent
Weak surveillance, especially
where disease prevalence is
declining
Scaling up dog-bite prevention
and administering timely post-exposure
treatment (with or without
immunoglobulin)
Covering > 70% of dogs targeted
by vaccination programmes aimed
at reducing and subsequently
halting transmission of the infection
to humanss
Lack of ready-to-use tools,
including diagnostic tools.
Poor sanitary conditions and
roaming pigs
Greater diagnostic capacity and
wider availability of tools in healthcare
settings
Where feasible, integration of
control activities with those for
dog-borne diseases such as
rabies and leishmaniases or
sheep-borne diseases such as
brucellosissis
Availability of triclabendazole for
fascioliasis
Preventive chemotherapy
integrated with that used for the
prevention of schistosomiasis and
soil-transmitted helminthiases
Greater support from the veterinary
sector
Improved aquaculture practices
Greater community awareness
about rabies
Strengthened surveillance through
regional laboratory networks
Improved access to and availability
of safe and affordable human
vaccine
Improved access to and availability
of dog vaccine
Integrated use of available
improved tools to reduce
tapeworm infection in people and
cysticercosis in people and pigs
Decreased prevalence in humans
Incidence of human cases
progressively reduced
Morbidity reduced and associated
mortality prevented
Morbidity reduced and associated
mortality prevented
Zero deaths attributed to rabies
Zero deaths attributed to rabies
Transmission of disease
interrupted
Improved understanding through
monitoring and evaluation of
impact of strategy on infection in
humans and pigs
Interventions Scaled up in
selected countries for control and
elimination of T. solium taeniasis
and (neuro)cysticercosis (2020)
The diffi culty of preventing
recrudescence of infection
following elimination
Accelerated reduction of T. solium
taeniasis and (neuro)cysticercosis